Editorial
doi: 10.1111/apt.14903.
Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first line therapy in inflammatory bowel disease
Affiliations
- PMID: 30132941
- DOI: 10.1111/apt.14903
Item in Clipboard
Editorial
Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first line therapy in inflammatory bowel disease
Aliment Pharmacol Ther.
2018 Sep.
No abstract available
Comment in
-
Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first-line therapy in inflammatory bowel disease. Authors' reply.Aliment Pharmacol Ther. 2018 Sep;48(6):684-685. doi: 10.1111/apt.14917. Aliment Pharmacol Ther. 2018. PMID: 30132943 No abstract available.
Comment on
-
Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study.Aliment Pharmacol Ther. 2018 Jul;48(2):196-205. doi: 10.1111/apt.14822. Epub 2018 Jun 5. Aliment Pharmacol Ther. 2018. PMID: 29869804
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources